Both in Pharmaceuticals
Oruka Therapeutics vs Alkermes
Over the past year ORKA returned +280.1% and ALKS returned +51.4%; their daily moves had a correlation of 0.27.
ORKA +280.1% ALKS +51.4%Growth of $1, one year, split-adjusted
| Metric | ORKA | ALKS |
|---|---|---|
| Price | $99.55 | $45.69 |
| Market cap | $6.59B | $7.67B |
| Today | +4.32% | +1.78% |
| 1 month | +18.0% | +6.9% |
| 6 months | +44.4% | +26.0% |
| Year to date | +228.4% | +63.3% |
| 1 year | +253.4% | +48.8% |
| Revenue growth (YoY) | — | +27.0% |
| Gross margin | — | 80.2% |
| Net margin | — | 0.1% |
| P/E (TTM) | — | 115.9× |
| Price / sales | — | 4.6× |
| Net cash | $873.6M | -$846.5M |
| Dividend yield | — | — |
| Volatility (60d) | 51.7% | 31.7% |
| Short % of float | 11.5% | 11.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).